Indeed, IL-6 has been shown to exert pro-inflammatory and pro-fibrotic effects, by stimulating fibroblasts, both in preclinical and in vivo studies of IPF and non-IPF ILD patients (59). This evidence concerns the gene IL6 and idiopathic pulmonary fibrosis.